Companies
Kintiga
a pan-European market-access consultancy whose in-house AI tool (EPRI) compressed a full German AMNOG HTA dossier's production to three months, alongside direct AMNOG negotiation support.
- Country
- United Kingdom
AI-Assisted
EU
Coverage
| CN | EU | US | |
|---|---|---|---|
| regulatory-legal | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Founded | 2024 | bouncewatch.com · kintiga.com · mergr.com · gp-intel.com · thecompanycheck.com |
| Revenue | $1M-$10M estimated medium confidence | bouncewatch.com |
| Headcount | 90-100 employees | bouncewatch.com |
| Funding | Owned by Kester Capital since 2023 | c.parsers.vc · mergr.com · gp-intel.com · thecompanycheck.com |
| Headquarters | Cambridge, United Kingdom | bouncewatch.com · kintiga.com |
Independent sources: bouncewatch.com · c.parsers.vc · gp-intel.com · mergr.com · thecompanycheck.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| HTA dossier preparation | regulatory-legal | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.